Literature DB >> 11782651

Menopause, estrogen, and training effects on exercise hemodynamics: the HERITAGE study.

John S Green1, Philip R Stanforth, Jacques Gagnon, Arthur S Leon, D C Rao, James S Skinner, Claude Bouchard, Tuomo Rankinen, Jack H Wilmore.   

Abstract

PURPOSE: To investigate the influences of menopause, hormone replacement, and endurance exercise training on cardiovascular hemodynamics and oxygen uptake parameters during exercise in women.
METHODS: Subjects were 338 premenopausal women, 29 postmenopausal women taking hormone replacement, and 28 postmenopausal women not taking hormone replacement, all enrolled in the HERITAGE Family Study. Hemodynamic and oxygen uptake data were gathered on a cycle ergometer at 50 watts (W), 60% peak oxygen uptake, and at peak exercise, both before and after a 20-wk regimen of endurance exercise training on a cycle ergometer.
RESULTS: Systolic blood pressure (SBP) during peak exercise was found to be an average of 14 mm Hg less in postmenopausal women receiving hormones than in those not receiving hormones. Furthermore, menopause was associated with a 26.2 mm Hg higher SBP at 50 W power output, which remained physiologically significant after adjustment for age. At 50 W, postmenopausal women not taking hormones showed a 13.8 mm Hg greater training-induced reduction in SBP than those taking hormones.
CONCLUSION: It was concluded that hormone replacement may be associated with a vasodilatory reserve at high exercise intensities and that endurance exercise training elicits favorable hemodynamic and oxygen uptake adaptations during exercise that are, in most instances, independent of menstrual status or hormone replacement.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782651     DOI: 10.1097/00005768-200201000-00013

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  7 in total

Review 1.  Effects of estrogen replacement on metabolic factors that influence physical performance in female hypogonadism.

Authors:  W M Kohrt; R E Van Pelt; W S Gozansky
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

2.  Influence of age, sex, and aerobic capacity on forearm and skin blood flow and vascular conductance.

Authors:  Gary J Hodges; Lisa Sharp; Richard E Clements; David F Goldspink; Keith P George; Nigel T Cable
Journal:  Eur J Appl Physiol       Date:  2010-03-31       Impact factor: 3.078

3.  The effect of lifelong endurance exercise on cardiovascular structure and exercise function in women.

Authors:  Graeme Carrick-Ranson; Nikita M Sloane; Erin J Howden; Paul S Bhella; Satyam Sarma; Shigeki Shibata; Naoki Fujimoto; Jeffrey L Hastings; Benjamin D Levine
Journal:  J Physiol       Date:  2020-05-21       Impact factor: 5.182

4.  Sex-specific effect of aging on submaximal leg exercise hemodynamics in middle-aged and older adults.

Authors:  Beth Parker; Jeffrey Capizzi; Amanda Augeri; Adam Grimaldi; David Proctor; Paul Thompson
Journal:  Eur J Appl Physiol       Date:  2010-12-14       Impact factor: 3.078

5.  Augmented sympathetic vasoconstriction in exercising forearms of postmenopausal women is reversed by oestrogen therapy.

Authors:  Paul J Fadel; Zhongyun Wang; Hitoshi Watanabe; Debbie Arbique; Wanpen Vongpatanasin; Gail D Thomas
Journal:  J Physiol       Date:  2004-10-21       Impact factor: 5.182

Review 6.  The HERITAGE Family Study: A Review of the Effects of Exercise Training on Cardiometabolic Health, with Insights into Molecular Transducers.

Authors:  Mark A Sarzynski; Treva K Rice; Jean-Pierre Després; Louis Pérusse; Angelo Tremblay; Philip R Stanforth; André Tchernof; Jacob L Barber; Francesco Falciani; Clary Clish; Jeremy M Robbins; Sujoy Ghosh; Robert E Gerszten; Arthur S Leon; James S Skinner; D C Rao; Claude Bouchard
Journal:  Med Sci Sports Exerc       Date:  2022-05-01

7.  Ageing and cardiorespiratory response to hypoxia.

Authors:  François J Lhuissier; Florence Canouï-Poitrine; Jean-Paul Richalet
Journal:  J Physiol       Date:  2012-08-20       Impact factor: 5.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.